IQVIA Holdings Inc

1IQV

Company Profile

  • Business description

    Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

  • Contact

    2400 Ellis Road
    DurhamNC27703
    USA

    T: +1 919 998-2000

    E: [email protected]

    https://www.iqvia.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    90,000

Stocks News & Analysis

stocks

Overvalued ASX share as market underestimates downside risks

Growth outlook solid, but upside more than priced in.
stocks

New production imminent for undervalued ASX gas play

LNG project receives first commissioning gas.
stocks

Going into earnings, is Tesla stock a buy, a sell, or fairly valued?

Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,324.6040.800.44%
CAC 408,189.4915.290.19%
DAX 4024,208.65377.661.58%
Dow JONES (US)46,396.40205.790.45%
FTSE 1009,400.5946.020.49%
HKSE25,858.83611.732.42%
NASDAQ22,851.45171.470.76%
Nikkei 22549,185.501,603.353.37%
NZX 50 Index13,344.9655.750.42%
S&P 5006,703.4239.410.59%
S&P/ASX 2009,031.9043.700.49%
SSE Composite Index3,863.8924.140.63%

Market Movers